Mylan Reveals FDA Goal Date For Bevacizumab

Mylan And Biocon Weighing Up A Third Biosimilar Launch

 
• By Dean Rudge
  
Thumbs up
Mylan's bevacizumab filing has been accepted for filing by the FDA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products